4.8 Article

Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters

Journal

NATURE COMMUNICATIONS
Volume 13, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41467-022-34439-7

Keywords

-

Funding

  1. Flemish Research Foundation (FWO) emergency COVID-19 fund [G0G4820N]
  2. FWO Excellence of Science (EOS) program [30981113, 40007527]
  3. European Union [101003627, 733176]
  4. Bill and Melinda Gates Foundation [INV-00636]
  5. KU Leuven Internal Funds [C3/19/057, C14/18/094]
  6. European Health Emergency Preparedness and Response Authority (HERA)
  7. Research Foundation-Flanders (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen) [G0E1420N, G098321N]
  8. European Research Council under the European Union [725422-ReservoirDOCS]
  9. EU [874850 MOOD]
  10. KU Leuven/UZ Leuven Covid-19 Fund (COVAX-PREC project)

Ask authors/readers for more resources

This study demonstrates the need to update current first-generation COVID-19 vaccines to maintain efficacy against emerging variants of concern. It also assesses the protective effects and reduced transmission of a yellow fever 17D vectored vaccine candidate in a hamster model.
Current COVID-19 vaccines are based on prototypic spike sequences from ancestral 2019 SARS-CoV-2 strains. However, the ongoing pandemic is fueled by variants of concern (VOC) escaping vaccine-mediated protection. Here we demonstrate how immunization in hamsters using prototypic spike expressed from yellow fever 17D (YF17D) as vector blocks ancestral virus (B lineage) and VOC Alpha (B.1.1.7) yet fails to fully protect from Beta (B.1.351). However, the same YF17D vectored vaccine candidate with an evolved antigen induced considerably improved neutralizing antibody responses against VOCs Beta, Gamma (P.1) and the recently predominant Omicron (B.1.1.529), while maintaining immunogenicity against ancestral virus and VOC Delta (B.1.617.2). Thus vaccinated animals resisted challenge by all VOCs, including vigorous high titre exposure to the most difficult to cover Beta, Delta and Omicron variants, eliminating detectable virus and markedly improving lung pathology. Finally, vaccinated hamsters did not transmit Delta variant to non-vaccinated cage mates. Overall, our data illustrate how current first-generation COVID-19 vaccines may need to be updated to maintain efficacy against emerging VOCs and their spread at community level. Currently licensed COVID-19 vaccines are based on antigen sequences of early SARS-CoV-2 isolates, despite the prevalence of variants of concerns escaping vaccine-mediated protection. Using their updated yellow fever 17D vectored candidate, here, authors assess neutralising antibody responses against variants of concern, and demonstrate protection and reduced transmission in a hamster model.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available